FDA Issues Warning Letter for Forest Laboratories' Bystolic Tablets
ROCK VILLE, Md., Sept. 8--The FDA posted on its web site a warning letter to Forest Laboratories, Inc. about a journal ad for its hypertension treatment Bystolic Tablets. The letter and journal ad are attached.
Posted: September 2008
Recommended for you